Abstract |
In order to evaluate the possible therapeutical effects of reduced glutathione in subjects affected by acquired or congenital heme biosynthesis alterations, two groups of subjects have been considered: the first, of 5 subjects with abnormal lead absorption, the second of 10 patients suffering from porphyria cutanea tarda (PCT). The drug was administered i.v. at the dosage of 600-1200 mg for a variable period of 3-5 days in the first group, for 7-10 days in the patients with PCT. In the lead-exposed subjects an increase in the activity of ALA- dehydratases enzyme was observed, with a decrease in the urinary excretion of delta-aminolevulinic acid, and a decrease in the percentage of urinary coproporphyrins as well. In the patients with PCT, after the therapy, a relevant reduction of urinary excretion of porphyrins, prevalently uro- and heptaporphyrins, was noticed. The results of this preliminary study suggest that glutathione can exert an effect of "normalization" on heme biosynthesis when altered in acquired and/or congenital conditions.
|
Authors | A Ferioli, A De Vincentiis, P Buizza, G Pasolini, C Leali, G De Panfilis, L Alessio |
Journal | Minerva medica
(Minerva Med)
Vol. 83
Issue 5
Pg. 269-75
(May 1992)
ISSN: 0026-4806 [Print] Italy |
Vernacular Title | Valutazione degli effetti del glutatione ridotto in soggetti con alterazioni acquisite e congenite della biosintesi dell'eme. |
PMID | 1589131
(Publication Type: Comparative Study, English Abstract, Journal Article)
|
Chemical References |
- Coproporphyrins
- Porphyrins
- Uroporphyrins
- Heme
- Aminolevulinic Acid
- Glutathione
|
Topics |
- Aminolevulinic Acid
(urine)
- Coproporphyrins
(urine)
- Glutathione
(administration & dosage, therapeutic use)
- Heme
(biosynthesis)
- Humans
- Lead Poisoning
(drug therapy, metabolism)
- Porphyrias
(drug therapy, metabolism)
- Porphyrins
(urine)
- Skin Diseases
(drug therapy, metabolism)
- Time Factors
- Uroporphyrins
(urine)
|